Search
Sign In
Sign In
Sources
8 Total Sources
Novo Nordisk Says Ziltivekimab Failed Large Trial, Challenging Heart Inflammation Theory
Left
60%
Center
20%
Right
20%
All
8
Left
3
Center
1
Right
1
Others
3
The New York Times
29d ago
Novo Nordisk's Ziltivekimab Fails Study, Challenges Heart Disease Inflammation Theory
Reuters
30d ago
Lilly beats estimates on resilient demand for injectable GLP-1 drugs, widens gap with Novo | Reuters
CNBC
30d ago
Eli Lilly and Novo Nordisk's Diverging Investor Fortunes Post-Earnings
pomegra.io
30d ago
Eli Lilly Q2 2026: Revenue Hits $23B, Guidance Raised - Pomegra News
MarketWatch
30d ago
How Ozempic maker Novo Nordisk blew its lead in GLP-1 weight-loss drugs. Can Europe compete in the high-stakes global economy? - MarketWatch
Simply Wall St
30d ago
Novo Nordisk Stock Shock Has Investors Rethinking Obesity Drug Exposure - Simply Wall St News
tickeron.com
30d ago
Why Is Insulet Corporation (PODD) Stock Down -19.54% Today?
AOL
30d ago
Lilly beats estimates on resilient demand for injectable GLP-1 drugs, widens gap with Novo - AOL